Attached files
| file | filename |
|---|---|
| 10-K - 10-K - HERON THERAPEUTICS, INC. /DE/ | d126077d10k.htm |
| EX-31.2 - EX-31.2 - HERON THERAPEUTICS, INC. /DE/ | d126077dex312.htm |
| EX-31.1 - EX-31.1 - HERON THERAPEUTICS, INC. /DE/ | d126077dex311.htm |
| EX-32.1 - EX-32.1 - HERON THERAPEUTICS, INC. /DE/ | d126077dex321.htm |
| EX-10.36 - EX-10.36 - HERON THERAPEUTICS, INC. /DE/ | d126077dex1036.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statements on Form S-3 (Nos. 333-190550, 333-195928 and 333-198862) and Form S-8 (Nos. 333-35151, 333-90428, 333-118546, 333-127574, 333-137954, 333-148660, 333-162610, 333-167515, 333-176365, 333-176366, 333-190549, 333-198853, 333-202588 and 333-206165) of Heron Therapeutics, Inc. of our reports dated February 18, 2016 relating to the consolidated financial statements and the effectiveness of Heron Therapeutics, Inc.’s internal control over financial reporting, which appear in this Annual Report on Form 10-K.
/s/ OUM & CO. LLP
San Francisco, California
February 18, 2016